Dodd Susanna, White Ian R, Williamson Paula
Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GS, UK.
MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge, CB2 0SR, UK.
Trials. 2017 Oct 25;18(1):498. doi: 10.1186/s13063-017-2240-9.
When a randomised trial is subject to deviations from randomised treatment, analysis according to intention-to-treat does not estimate two important quantities: relative treatment efficacy and effectiveness in a setting different from that in the trial. Even in trials of a predominantly pragmatic nature, there may be numerous reasons to consider the extent, and impact on analysis, of such deviations from protocol. Simple methods such as per-protocol or as-treated analyses, which exclude or censor patients on the basis of their adherence, usually introduce selection and confounding biases. However, there exist appropriate causal estimation methods which seek to overcome these inherent biases, but these methods remain relatively unfamiliar and are rarely implemented in trials.
This paper demonstrates when it may be of interest to look beyond intention-to-treat analysis for answers to alternative causal research questions through illustrative case studies. We seek to guide trialists on how to handle treatment changes in the design, conduct and planning the analysis of a trial; these changes may be planned or unplanned, and may or may not be permitted in the protocol. We highlight issues that must be considered at the trial planning stage relating to: the definition of nonadherence and the causal research question of interest, trial design, data collection, monitoring, statistical analysis and sample size.
During trial planning, trialists should define their causal research questions of interest, anticipate the likely extent of treatment changes and use these to inform trial design, including the extent of data collection and data monitoring. A series of concise recommendations is presented to guide trialists when considering undertaking causal analyses.
当一项随机试验存在偏离随机治疗的情况时,按照意向性分析并不能估计两个重要的量:相对治疗效果以及在与试验不同的环境中的有效性。即使在主要具有实用性的试验中,也可能有许多理由去考虑这种偏离方案的程度及其对分析的影响。诸如符合方案分析或实际治疗分析等简单方法,它们基于患者的依从性来排除或删失患者,通常会引入选择偏倚和混杂偏倚。然而,存在一些合适的因果估计方法试图克服这些内在偏倚,但这些方法仍然相对不为人熟悉,并且在试验中很少被采用。
本文通过实例研究来说明何时超越意向性分析去寻找替代因果研究问题的答案可能是有意义的。我们试图指导试验者如何在试验的设计、实施和分析规划中处理治疗变更;这些变更可能是计划内的或计划外的,并且在方案中可能允许也可能不允许。我们强调在试验规划阶段必须考虑的问题,包括:不依从的定义以及感兴趣的因果研究问题、试验设计、数据收集、监测、统计分析和样本量。
在试验规划期间,试验者应明确他们感兴趣的因果研究问题,预测治疗变更的可能程度,并利用这些来为试验设计提供信息,包括数据收集的范围和数据监测。本文提出了一系列简洁的建议,以指导试验者在考虑进行因果分析时的操作。